- Rheumatoid arthritis
- Polyarticular juvenile idiopathic arthritis
- Enthesitis-related arthritis
- Ankylosing spondylitis
- Axial spondyloarthritis without radiographic evidence of ankylosing spondylitis
- Psoriatic arthritis
- Plaque psoriasis
- Hidradenitis suppurativa
- Crohn’s disease
- Ulcerative colitis
- Non-infectious uveitis
AZIMBRA
MRP | : |
|
Price | : | ₹9,000.00 |
You Save | : | ₹12,825.00 (58.76%) |
1 prefilled syringe(s)
Azimbra 40mg Injection, an antirheumatic agent containing the active compound Adalimumab, belongs to the class of medications known as TNF (tumor necrosis factor) inhibitors. It is utilized to manage the symptoms of various autoimmune diseases, either as a standalone therapy or in conjunction with other drugs.
However, there are important contraindications and precautions associated with its use. Azimbra 40mg Injection is not recommended if you have an allergy to Adalimumab or any other ingredients in the medicine. It is also advised against if you are suffering from severe infections, such as tuberculosis or sepsis, or any other significant infection, or if you have a compromised immune system. Patients with moderate or severe heart failure should also avoid this medication. Before initiating any treatment with Azimbra 40mg Injection, it is crucial to inform your doctor if you have any active infection, or any pre-existing heart, liver, or renal issues. Children aged six or below should consult their doctor before using Azimbra 40mg Injection. Geriatric patients over 65 years old are more susceptible to infections while on this medication, thus close monitoring for side effects is essential. It is also advised to ensure your child has an up-to-date vaccination schedule to minimize the risk of developing infections.
The decision to use Azimbra 40mg Injection during pregnancy and breastfeeding will be made by your doctor only if it is deemed absolutely necessary, as there is a potential risk of infections to the child. Women of reproductive age are recommended to use effective contraceptive methods throughout the therapy and for at least five months after its completion. You should inform your doctor if you are pregnant or planning to get pregnant to discuss appropriate contraceptive methods. Furthermore, it is essential to disclose all medicines, over-the-counter drugs, vitamin, and herbal supplements you are currently taking to your physician before commencing therapy. Patients receiving Azimbra 40mg Injection should be closely monitored by their healthcare provider for any signs of side effects.